← SynDRA
RUFLOXACIN
SynDRA canonical compound SYN0002351 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | bacterial DNA gyrase inhibitor |
|---|
| Indication | gram-negative bacterial infections |
|---|
| Disease area | infectious disease |
|---|
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRA2B
- ADORA1
- NPY1R
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KAT2A
- KCNH2
- KDM4E
- MAOA
- MAPK1
- MBNL1
- MC3R
- MLNR
- NR1I2
- HRH3
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PIN1
- PTGS2
- SAMHD1
- SLC6A3
- SLC6A4
- TBXA2R
- HSD17B10
- HRH2
- ADORA2A
- HRH1
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2C
- ADRB1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CAC1B
- IF4H
- KLK7
- PABP1
- PRGR
- SC5A7
Drug classes
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
Cross-references
Synonyms
- rufloxacin hydrochloride
- rufloxacin hydrobromide
- MF-934
- Rufloxacine
- Rufloxacino
- MF 934
- NSC-759835
- Rufloxacinum
- Monos
- NSC 759835
- Y521XM2900
- Tebraxin
- rufloxacina
- Uroflox
- RefChem:180288
- rufloxacin monohydrobromide
- DTXCID4028385
- J01MA10
- C17H18FN3O3S
- Rufloxacin (INN)
- RUFLOXACIN [INN]
- SMR000466373
- Rufloxacine [French]
- Rufloxacinum [Latin]
- Rufloxacino [Spanish]
- Rufloxacin [INN:BAN]
- SR-01000612324
- NCGC00074024-02
- UNII-Y521XM2900
- RUFLOXACIN [MI]
- RUFLOXACIN [WHO-DD]
- MLS000759502
- MLS001424127
- SCHEMBL135502
- CHEBI:8909
- orb1705275
- GTPL12473
- NJCJBUHJQLFDSW-UHFFFAOYSA-N
Look up RUFLOXACIN in the interactive SynDRA portal →